The PRKD1 Gene Congenital Heart Defects and Ectodermal Dysplasia Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to detect mutations in the PRKD1 gene, which have been associated with congenital heart defects and ectodermal dysplasia. This test is crucial for individuals showing symptoms or having a family history of these conditions, providing them with valuable insights into their genetic makeup.
Congenital heart defects encompass a range of abnormalities in the heart's structure present from birth, affecting the overall heart function. Ectodermal dysplasia refers to a group of disorders that affect the development of the ectodermal structures, including the skin, hair, nails, teeth, and sweat glands. Mutations in the PRKD1 gene can lead to disruptions in normal development processes, resulting in the manifestations of these conditions.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the PRKD1 gene. This genetic testing can provide essential information for the diagnosis, management, and treatment planning of affected individuals, offering a targeted approach to care.
At DNA Labs UAE, the cost of the PRKD1 Gene Congenital Heart Defects and Ectodermal Dysplasia Genetic Test is set at 4400 AED. This investment includes the full process of sample collection, genetic analysis, and a comprehensive report detailing the findings. Given the intricate nature of genetic testing and the profound impact it can have on patient care, this test represents a valuable tool for individuals at risk of these genetic conditions, enabling proactive health management and informed decision-making.
The "FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the FOXH1 gene that are associated with congenital heart diseases, particularly Transposition of the Great Arteries (TGA). This condition is a serious congenital heart defect where the two main arteries leaving the heart are reversed, leading to significant complications in blood circulation. The test aims to provide crucial genetic information that can aid in the early diagnosis, management, and treatment planning for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test utilizes advanced genomic technologies to accurately detect any genetic abnormalities linked to these heart conditions. By analyzing a small sample of the patient's DNA, the test can identify specific mutations in the FOXH1 gene that are known to contribute to the development of congenital heart diseases.
The cost of the FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated genetic analysis and the expertise required to interpret the results accurately.
For families with a history of congenital heart disease or individuals showing symptoms related to TGA, this test provides an invaluable tool for early detection and intervention, potentially improving the outcomes and quality of life for those affected.
The CLMP Gene Congenital Short-Bowel Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CLMP gene, which are associated with congenital short-bowel syndrome (CSBS). CSBS is a rare, inherited disorder characterized by a significantly shorter small intestine, which can lead to severe malabsorption, nutritional deficiencies, and a range of other gastrointestinal complications from birth. Early and accurate diagnosis through genetic testing can be crucial for managing the condition effectively.
Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect specific mutations in the CLMP gene that indicate the presence of CSBS. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, which is known for its advanced diagnostic technologies and expert team of geneticists and laboratory technicians. The result from this test can provide essential information for the clinical management of affected individuals, including dietary modifications, nutritional supplementation, and, in some cases, surgical interventions to alleviate symptoms and improve quality of life.
Given the complexity and rarity of congenital short-bowel syndrome, the CLMP Gene test is a valuable resource for families seeking answers to unexplained gastrointestinal symptoms in their children, enabling them to take informed steps towards treatment and care.
The "ARX Gene Corpus Callosum Agenesis with Abnormal Genitalia Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ARX gene, which are associated with a rare congenital disorder. This condition is characterized by the underdevelopment or absence of the corpus callosum, the structure that connects the two hemispheres of the brain, alongside abnormalities in genitalia. The test is crucial for early diagnosis and management of the condition, helping healthcare providers to tailor treatment and support for affected individuals. The cost of the test is 4400 AED, making it an accessible option for those in need of this specific genetic analysis in the UAE. This test represents an important step forward in the field of genetic diagnostics, offering hope and answers to families affected by this rare condition.
The LAMC3 gene is associated with various cortical malformations, particularly in the occipital region of the brain. These malformations can lead to a range of neurological disorders and developmental issues. The LAMC3 Gene Cortical Malformations Occipital Genetic Test is a specialized diagnostic tool designed to identify mutations in the LAMC3 gene that are linked to these brain abnormalities. This test is crucial for early detection, allowing for appropriate intervention and management of conditions related to cortical malformations.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the LAMC3 gene. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable results. The test cost is set at 4400 AED, reflecting the sophisticated nature of the genetic analysis and the expertise required to interpret the results. By opting for this test, individuals can gain valuable insights into their genetic makeup, empowering them with information that can guide medical and lifestyle decisions.
Costello Syndrome is a rare genetic disorder that affects multiple systems of the body. It is characterized by delayed development, intellectual disability, distinctive facial features, and a predisposition to certain cancers. The syndrome is caused by mutations in the HRAS gene, which plays a crucial role in cell growth and division.
The HRAS Gene Costello Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the HRAS gene that are associated with Costello Syndrome. This test is crucial for the accurate diagnosis of the syndrome, enabling early intervention and management of the condition. It involves analyzing the patient's DNA to identify any genetic alterations in the HRAS gene that may lead to the development of Costello Syndrome.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the HRAS Gene Costello Syndrome Genetic Test is 4400 AED. This comprehensive testing service is conducted by experienced professionals using state-of-the-art technology to ensure accurate and reliable results. With this test, families can gain valuable insights into their genetic health, empowering them to make informed decisions regarding the management and treatment of Costello Syndrome.
TBX15 Gene Cousin Syndrome Genetic Test is a specialized diagnostic assessment designed to detect mutations in the TBX15 gene, which is crucial for the development and function of various tissues in the body. Mutations in this gene have been linked to Cousin Syndrome, a rare genetic disorder characterized by skeletal abnormalities, short stature, and distinctive facial features. The test aims to provide a definitive diagnosis for individuals suspected of having Cousin Syndrome, enabling targeted management and genetic counseling for affected families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test utilizes advanced genetic sequencing technologies to accurately identify mutations in the TBX15 gene. This precise approach ensures reliable results, offering crucial insights into the patient's condition and guiding further medical or therapeutic interventions.
The cost of the TBX15 Gene Cousin Syndrome Genetic Test is 4400 AED. This investment covers the comprehensive analysis and expert interpretation of the genetic data, ensuring that patients and their healthcare providers receive detailed and actionable information. With the support of DNA Labs UAE, individuals undergoing this test can expect a high standard of care and confidentiality throughout the process.
Craniodiaphyseal dysplasia is a rare genetic disorder characterized by the abnormal development of bones in the skull and face, leading to a distinctive facial appearance and potential neurological complications due to pressure on the brain. The SOST gene plays a critical role in bone formation and density, and mutations in this gene have been associated with the autosomal dominant form of craniodiaphyseal dysplasia.
To diagnose this condition accurately and to guide treatment plans, genetic testing of the SOST gene can be performed. DNA Labs UAE offers a specific genetic test for the SOST gene to identify mutations that cause craniodiaphyseal dysplasia. The test is priced at 4400 AED and is a crucial step for families seeking answers to their medical questions, particularly for those with a history of the disorder or presenting with symptoms suggestive of craniodiaphyseal dysplasia.
This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the SOST gene. The results can provide valuable information for diagnosis, prognosis, and familial planning, offering insights into the likelihood of passing the condition on to future generations.
The IFT122 gene plays a crucial role in the development and maintenance of the body's structure, particularly in relation to cranioectodermal dysplasia type 1, a rare genetic disorder. This condition is characterized by abnormalities in the development of the skull, fingers, toes, and other parts of the skeleton, as well as potential issues with the kidneys and liver. A genetic test for this condition can provide crucial information for diagnosis, management, and treatment planning.
DNA Labs UAE offers a specific genetic test targeting the IFT122 gene to identify mutations associated with cranioectodermal dysplasia type 1. This test is essential for families with a history of the condition or for individuals showing symptoms suggestive of this disorder. By analyzing a sample of the patient's DNA, the test can confirm the presence of the genetic mutations responsible for the condition, thereby facilitating early and accurate diagnosis.
The cost of the IFT122 gene cranioectodermal dysplasia type 1 genetic test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory by experienced geneticists and technicians, ensuring high accuracy and reliability of the results. The investment in this test is a crucial step towards understanding the genetic basis of the condition and can significantly impact the clinical management and quality of life of those affected.
The WDR35 Gene Cranioectodermal Dysplasia Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the WDR35 gene that are responsible for Cranioectodermal Dysplasia Type 2, a rare genetic disorder. This condition, also known as Sensenbrenner syndrome, is characterized by skeletal abnormalities, ectodermal dysplasia (affecting skin, hair, and nails), and other systemic defects. Early diagnosis through genetic testing can be crucial for managing symptoms and improving the quality of life for affected individuals. The test is priced at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of the specific genetic mutations within the WDR35 gene. Conducted at DNA Labs UAE, this test offers a valuable resource for families seeking answers to complex genetic conditions.
